Karleen M. Oberton
Net Worth

Last updated:

What is Karleen M. Oberton net worth?

The estimated net worth of Ms. Karleen M. Oberton is at least $28,268,203 as of 29 Aug 2024. She owns shares worth $5,682,920 as insider, has earned $6,635,283 from insider trading and has received compensation worth at least $15,950,000 in Hologic, Inc..

What is the salary of Karleen M. Oberton?

Ms. Karleen M. Oberton salary is $1,450,000 per year as Chief Financial Officer in Hologic, Inc..

How old is Karleen M. Oberton?

Ms. Karleen M. Oberton is 55 years old, born in 1970.

What stocks does Karleen M. Oberton currently own?

As insider, Ms. Karleen M. Oberton owns shares in one company:

Company Title Shares Price per share Total value
Hologic, Inc. (HOLX) Chief Financial Officer 84,042 $67.62 $5,682,920

What does Hologic, Inc. do?

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Karleen M. Oberton insider trading

Hologic, Inc.

Ms. Karleen M. Oberton has made 24 insider trades between 2014-2024, according to the Form 4 filled with the SEC. Most recently she sold 52,679 units of HOLX stock worth $4,243,662 on 29 Aug 2024.

The largest trade she's ever made was exercising 52,679 units of HOLX stock on 29 Aug 2024. As of 29 Aug 2024 she still owns at least 84,042 units of HOLX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 52,679 $80.56 $4,243,662
Option
Common Stock 26,080 $40.97 $1,068,498
Option
Common Stock 6,725 $40.85 $274,716
Option
Non-qualified Stock Option (Right to Buy) 32,805 $40.91 $1,342,053
Sale
Common Stock 14,940 $75 $1,120,500
Option
Common Stock 7,389 $37.64 $278,122
Sale
Common Stock 14,545 $72.5 $1,054,513
Option
Non-qualified Stock Option (Right to Buy) 7,389 $37.64 $278,122
Option
Common Stock 7,156 $39.96 $285,954
Option
Non-qualified Stock Option (Right to Buy) 5,461 N/A N/A
Option
Common Stock 5,461 N/A N/A
Option
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 15,000 N/A N/A
Option
Common Stock 16,348 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 10,375 N/A N/A
Sale
Common Stock 16,348 N/A N/A
Sale
Common Stock 1,312 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 1,860 N/A N/A
Sale
Common Stock 3,806 N/A N/A
Option
Common Stock 1,860 N/A N/A
Sale
Common Stock 546 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 775 N/A N/A
Option
Common Stock 775 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 525 N/A N/A
Option
Common Stock 525 N/A N/A
Option
Common Stock 12,196 $28.55 $348,135
Option
Common Stock 12,196 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 4,202 N/A N/A
Sale
Common Stock 4,202 N/A N/A
Sale
Common Stock 1,023 N/A N/A
Option
Common Stock 1,515 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 1,515 N/A N/A
Sale
Common Stock 1,256 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 1,860 N/A N/A
Option
Common Stock 1,860 N/A N/A
Sale
Common Stock 538 N/A N/A
Option
Common Stock 797 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 797 N/A N/A
Sale
Common Stock 4,704 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 525 N/A N/A
Option
Common Stock 525 N/A N/A
Sale
Common Stock 3,023 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 5,710 N/A N/A
Option
Common Stock 5,710 N/A N/A
Sale
Common Stock 1,211 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 1,794 N/A N/A
Option
Common Stock 1,794 N/A N/A
Sale
Common Stock 984 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 1,860 N/A N/A
Option
Common Stock 1,860 N/A N/A
Sale
Common Stock 522 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 774 N/A N/A
Option
Common Stock 774 N/A N/A
Sale
Common Stock 31,470 N/A N/A
Option
Common Stock 31,470 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 31,470 N/A N/A
Option
Common Stock 4,753 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 4,228 N/A N/A
Sale
Common Stock 4,228 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 525 N/A N/A
Option
Common Stock 1,515 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 1,515 N/A N/A
Option
Common Stock 1,794 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 1,794 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 2,012 N/A N/A
Option
Common Stock 2,012 N/A N/A
Option
Common Stock 1,859 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 1,859 N/A N/A
Option
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 15,000 N/A N/A
Option
Common Stock 524 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 524 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 18,997 $24.93 $473,595
Sale
Common Stock 3,997 $19.86 $79,380
Option
Common Stock 18,997 $24.93 $473,595
Option
Restricted Stock Unit Award (Right To Receive) 1,515 $26.64 $40,360
Option
Common Stock 1,515 $26.64 $40,360
Option
Common Stock 1,794 $26.3 $47,182
Option
Restricted Stock Unit Award (Right To Receive) 1,794 $26.3 $47,182
Sale
Common Stock 1,253 $26.54 $33,255
Option
Common Stock 1,858 $26.55 $49,330
Sale
Common Stock 1,356 $26.08 $35,364
Option
Restricted Stock Unit Award (Right To Receive) 1,858 $26.55 $49,330
Option
Restricted Stock Unit Award (Right To Receive) 2,011 $26.21 $52,708
Option
Common Stock 2,011 $26.21 $52,708
Sale
Common Stock 4,079 $16.82 $68,609
Option
Common Stock 12,507 $23.49 $293,827
Option
Non-qualified Stock Option (Right to Buy) 12,507 $23.49 $293,827

Hologic key executives

Hologic, Inc. executives and other stock owners filed with the SEC: